Reply to Yamamoto and Iwata

Clinical Infectious Diseases

Volumn 47, Issue 3, 2008, Pages 432-433

  Jenkins, Timothy C ^a,b,c   Burman, William J ^a,b  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DENVER PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; BACTERIUM CULTURE; BLOOD CULTURE; CONSULTATION; FOLLOW UP; HUMAN; LETTER; PATIENT COMPLIANCE; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 47549098504     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/589927     Document Type: Letter

References (6)

1. Yamamoto S, Iwata K. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 47:432 (in this issue).
2. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:1000-8.
3. Harstein AI, Mulligan ME, Morthland VH, et al. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol 1992; 30:670-4.
4. Fowler VG, Olsen MK, Corey R, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163:2066-72.
5. Stryjewski ME, Szczech LA, Benjamin DK, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44:190-6.
6. Fowler VG, Sanders LL, Sexton DJ, et al. Outcomes of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27:478-86.